These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 32559663)

  • 1. Adipocytokines: Are they the Theory of Everything?
    Maximus PS; Al Achkar Z; Hamid PF; Hasnain SS; Peralta CA
    Cytokine; 2020 Sep; 133():155144. PubMed ID: 32559663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocytokines and obesity-linked disorders.
    Ouchi N; Ohashi K; Shibata R; Murohara T
    Nagoya J Med Sci; 2012 Feb; 74(1-2):19-30. PubMed ID: 22515108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cardiovascular health and disease by visceral adipose tissue-derived metabolic hormones.
    Vasamsetti SB; Natarajan N; Sadaf S; Florentin J; Dutta P
    J Physiol; 2023 Jun; 601(11):2099-2120. PubMed ID: 35661362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Role of Adipocytokines in Type 2 Diabetes as Mediators of Insulin Resistance and Cardiovascular Disease.
    Jaganathan R; Ravindran R; Dhanasekaran S
    Can J Diabetes; 2018 Aug; 42(4):446-456.e1. PubMed ID: 29229313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adipocytokines: modern definition, classification and physiological role].
    Markova TN; Mishchenko NK; Petina DV
    Probl Endokrinol (Mosk); 2021 Dec; 68(1):73-80. PubMed ID: 35262298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review.
    Hamjane N; Benyahya F; Nourouti NG; Mechita MB; Barakat A
    Microvasc Res; 2020 Sep; 131():104023. PubMed ID: 32485192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.
    Panera N; Della Corte C; Crudele A; Stronati L; Nobili V; Alisi A
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):393-403. PubMed ID: 26654761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities.
    Ruscitti P; Di Benedetto P; Berardicurti O; Liakouli V; Carubbi F; Cipriani P; Giacomelli R
    J Immunol Res; 2018; 2018():8410182. PubMed ID: 30584543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocytokines and the metabolic complications of obesity.
    Rasouli N; Kern PA
    J Clin Endocrinol Metab; 2008 Nov; 93(11 Suppl 1):S64-73. PubMed ID: 18987272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocytokines in obesity and metabolic disease.
    Cao H
    J Endocrinol; 2014 Feb; 220(2):T47-59. PubMed ID: 24403378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Roles of Adipocytokines and Myokines in Cardiovascular Disease.
    Ouchi N; Ohashi K; Shibata R; Murohara T
    Circ J; 2016 Sep; 80(10):2073-80. PubMed ID: 27581346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of adipocytokines in atherogenesis and atheroprogression.
    Carbone F; Mach F; Montecucco F
    Curr Drug Targets; 2015; 16(4):295-320. PubMed ID: 25382206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipokine Visfatin's Role in Pathogenesis of Diabesity and Related Metabolic Derangements.
    Kumari B; Yadav UCS
    Curr Mol Med; 2018; 18(2):116-125. PubMed ID: 29974830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines in glucose and lipid metabolism.
    Wang X; Zhang S; Li Z
    Adipocyte; 2023 Dec; 12(1):2202976. PubMed ID: 37077042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Adipocytokines in Coronary Atherosclerosis.
    Liberale L; Bonaventura A; Vecchiè A; Casula M; Dallegri F; Montecucco F; Carbone F
    Curr Atheroscler Rep; 2017 Feb; 19(2):10. PubMed ID: 28185154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.
    Stojsavljević S; Gomerčić Palčić M; Virović Jukić L; Smirčić Duvnjak L; Duvnjak M
    World J Gastroenterol; 2014 Dec; 20(48):18070-91. PubMed ID: 25561778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocytokines and hepatocellular carcinoma.
    Wieser V; Moschen AR; Tilg H
    Dig Dis; 2012; 30(5):508-13. PubMed ID: 23108307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis.
    Matarese G; Mantzoros C; La Cava A
    Curr Pharm Des; 2007; 13(36):3676-80. PubMed ID: 18220805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses.
    Yamawaki H
    Biol Pharm Bull; 2011; 34(3):307-10. PubMed ID: 21372376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
    Jung UJ; Choi MS
    Int J Mol Sci; 2014 Apr; 15(4):6184-223. PubMed ID: 24733068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.